Carpal tunnel syndrome is a frequently diagnosed condition in which the patient experiences pain, tingling, numbness, and atrophy of the muscles in the pattern of the median nerve, which affects the thumb, index finger, and middle finger.   Though splinting or other noninvasive measures may work for some, surgical treatment is the gold standard in which the tranverse carpal ligament is released at the wrist to take pressure off of the median nerve and reduce or alleviate symptoms.  Historically, the surgery was performed in open fashion in which a several cm incision was made from the wrist into the palm, the transverse carpal ligament was identified, and then the transverse carpal ligament was cut or resected.  This open surgery requires a larger incision and more down time for the patient.  Next the endoscopic treatment was formulated in which a smaller 1 cm incision was made to admit the endoscope and visualize the transection of the transverse carpal ligament.  This approach still required an operative setting in which most people underwent general anesthesia.  A few years ago, SX-One MicroKnife using ultrasound guidance was formulated to create a situation in which the release could be performed in the office setting under local anesthesia.

Millions of Americans suffer from carpal tunnel syndrome, and, in many, surgery is recommended.  These surgeries may not be performed due to inability to afford the procedure or the recovery time.   Patients who undergo the in office procedure recover in a few days using this minimally invasive technique versus several weeks for open surgery.

The device became available in 2019 and has been used in over 5,000 procedures swith excellent outcomes reported in multiple peer-review journals.

Please follow and like us: